BMO raises Equifax stock price target on mortgage outlook

BMO Capital raised its price target for Equifax (EFX) to $186 from $175, citing positive mortgage market outlook for 2027. The stock trades at $189.50, with a consensus high target of $245. Analysts have mixed views on EFX's future, with some highlighting strong earnings and others citing mortgage market challenges.

Original reporting
Published Nov 17, 2026, 1:56 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 17, 2026, 2:08 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$EFX
Bullish
medium confidence
Mentioned
$EFX
Relevance
4/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$EFXBullishLow
01

Why it matters

BMO’s target raise adds incremental bullish framing, but the stock is already above the new target and the article emphasizes ongoing mortgage headwinds and mixed Street ratings.

02

Market read

Traders may reassess near-term sentiment and positioning in EFX based on incremental bullish sell-side framing around 2027 mortgage outperformance, while keeping mortgage headwind and regulatory risk in view.

03

What to watch

The article flags remaining question marks around the phasing of Government in 2027, which could undermine the 2027 outperformance narrative if timing disappoints.

Relevance 4/10Novelty 4/10Timing: today, as a fresh analyst price-target update

Background

Equifax is a credit bureau whose near-term performance is sensitive to mortgage activity and scoring model dynamics (FICO/Vantage), with analysts debating how tough mortgage conditions will be into 2027.

Company-level read

Ticker impact

$EFXBullishMedium confidence
Context

BMO raised Equifax’s price target to $186 from $175 and turned more constructive, citing mortgage market outperformance expectations for 2027.

Expected impact

Likely mild upward bias as traders weigh the upgrade in the context of mixed analyst views on mortgage headwinds.

Evidence & confidence

The article is an analyst target change with a clear thesis (mortgage outperformance, FICO/Vantage, Government phasing), but it is not a new earnings/guidance print from Equifax itself.

Market effects

Reinforces the credit bureau and consumer credit data theme tied to mortgage volumes and scoring model dynamics.

Primarily US equity sentiment for credit-data and mortgage-linked financial services.

Limited, as the catalyst is a US-listed analyst target change.

Counterpoint

Other banks in the article cut targets or downgraded Equifax on persistent mortgage weakness and potential regulatory changes, which can cap follow-through from a single target raise.

Key entities

  • Equifax Inc.

    Credit bureau company; BMO raised its price target and maintained Market Perform rating based on mortgage outlook and scoring dynamics.

  • BMO Capital Markets

    Raised Equifax price target to $186 from $175 and cited mortgage market outperformance expectations for 2027.

  • Jeffrey M. Silber

    BMO analyst who adjusted the price target after a virtual call with Equifax investor relations.

Related articles

$EFXLow

Equifax's $100 Million Credit Score Settlement Could Pay Up to $280 Each to People Whose Scores Were Misreported in 2022, With Claims Due Dec. 28

Equifax has agreed to a $100 million settlement for misreported credit scores in 2022, affecting about 4 million people. Affected individuals can claim up to $280 each by Dec. 28, 2026. Equifax denies wrongdoing but settled to resolve the issue. The settlement covers those whose incorrect scores were sent to lenders during mortgage, auto loan, or credit card applications.

$EFXMed

Why Equifax (EFX) stock is down today

Equifax (EFX) shares fell 2.7% after RBC downgraded the stock to Sector Perform and raised its price target to $189. The downgrade cited valuation concerns and operating issues, including mortgage market weakness and regulatory risks. The stock later recovered slightly to $178.03, down 2.4%. Equifax's shares are down 16.8% year-to-date and 22.3% below their 52-week high.